Found 118 matching trials
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome PHASE2 The primary purpose of the study is to investigate the effects of high-dose...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Resection of the Esophagus and Subsequent Weight Loss N/A The investigators aim to ascertain how food reward signals and eating behav...
Show More Location
Conway Institute, UCD
Learn More & Join Trial
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) PHASE2 This is a Phase II, open-label multicentre, randomised study to assess the ...
Show More Location
Hospices Civils de Lyon
Learn More & Join Trial
Octreotide in Patients With GI Bleeding Due to Rendu-Osler-Weber PHASE2 The purpose of this study is to determine whether long-acting octreotide is...
Show More Learn More & Join Trial
Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer PHASE2 The aim of the study is to clarify whether octreotide therapy can reduce un...
Show More Location
Karolinska University Hospital, Huddinge
Learn More & Join Trial
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors PHASE2 Study evaluating SOM230 in patients with metastatic carcinoid tumors...
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Treatment of Orthostatic Intolerance PHASE1 This trial is designed to study the effects of various mechanistically uniq...
Show More Status
Active Not Recruiting
Location
Vanderbilt University Autonomic Dysfunction Center
Learn More & Join Trial
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor PHASE3 This randomized phase III trial studies octreotide acetate and recombinant ...
Show More Status
Active Not Recruiting
Location
Providence Hospital
Learn More & Join Trial
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma PHASE1 This phase I trial studies the side effects and best dose of cixutumumab wh...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea NA To determine the efficacy and safety of Sandostatin (octreotide) compared t...
Show More Location
USC School of Medicine
Learn More & Join Trial